NCT02262520View on ClinicalTrials.gov

Phase 1 Drug Interaction Study of the Effect of Apixaban on the PK of Digoxin in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
N/A - Healthy Subjects
Interventions
DRUG

Apixaban

DRUG

Digoxin

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Bristol-Myers Squibb

INDUSTRY